ATHA (Athira Pharma, Inc.) Stock Market Reviews

crown

search

Read and share opinions on ATHA (Athira Pharma, Inc.) stock. Join MyTopStock.com to discover reviews, insights, and discussions from investors about this company's performance in the stock market.

ATHA

Athira Pharma, Inc.

clarify Biotechnology

bookmark Healthcare

public United States

Sell Neutral Buy

Latest News

Athira Pharma Reports Third Quarter 2025 Financial Results and Provides Business Update
Nov 6, 2025
Athira Pharma Announces Reverse Stock Split
Sep 11, 2025
Athira Pharma Presents ATH-1105 Phase 1 Trial Results at ALS Nexus 2025
Aug 14, 2025
Athira Pharma Reports Second Quarter 2025 Financial Results and Provides Business Update
Aug 7, 2025
This Athira Pharma Insider Increased Their Holding By 111% Last Year
May 27, 2025
Athira Pharma to present data from first-in-human Phase 1 trial of ATH-1105
May 14, 2025
Athira Pharma to Present Data from First-in-Human Phase 1 Clinical Trial of ATH-1105 at the 4th Annual ALS Drug Development Summit
May 13, 2025
Athira Pharma Reports First Quarter 2025 Financial Results and Pipeline and Business Updates
May 9, 2025
Athira Pharma Reports Full Year 2024 Financial Results and Pipeline and Business Updates
Feb 27, 2025
Athira Pharma Insider Ups Holding By 111% During Year
Dec 18, 2024
Athira Pharma Presents Preclinical Data Highlighting Neuroprotective Effects of ATH-1105 in Models of ALS at Motor Neurone Disease Association’s 35th International Symposium on ALS/MND
Dec 6, 2024

Reviews